(Q41172484)

27 September 2017

1 reference

title

Amylin, amyloid and age-related disease (English)

1 reference

27 September 2017

G J Cooper

1

1 reference

27 September 2017

C A Tse

series ordinal

2

1 reference

27 September 2017

publication date

1 September 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

9

1 reference

27 September 2017

issue

3

1 reference

27 September 2017

page(s)

202-212

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199609030-00006

27 September 2017

exact match

0 references

cites work

In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle.

1 reference

12 December 2020

Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs.

1 reference

12 December 2020

Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues

1 reference

12 December 2020

Amylin modulates beta-cell glucose sensing via effects on stimulus-secretion coupling

1 reference

12 December 2020

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

1 reference

12 December 2020

Insulin resistance is a characteristic feature of primary hypertension independent of obesity.

1 reference

12 December 2020

Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals

1 reference

12 December 2020

Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas

1 reference

12 December 2020

Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets

1 reference

12 December 2020

Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp rats

1 reference

12 December 2020

Stimulation of adenylate cyclase by amylin in CHO-K1 cells

1 reference

12 December 2020

Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance.

1 reference

12 December 2020

Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic islets

1 reference

12 December 2020

IAPP/amylin transgenic mice as an in vivo model system for type-2 diabetes mellitus?

1 reference

12 December 2020

Daily amylin replacement reverses hepatic glycogen depletion in insulin-treated streptozotocin diabetic rats

1 reference

12 December 2020

Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus

1 reference

12 December 2020

Islet amyloid polypeptide-producing pancreatic islet cell tumor. A clinical and biochemical characterization

1 reference

12 December 2020

Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma

1 reference

12 December 2020

Role of islet amyloid polypeptide secretion in insulin-resistant humans.

1 reference

12 December 2020

Co-secretion of amylin and insulin from cultured islet β-cells: Modulation by nutrient secretagogues, islet hormones and hypoglycemic agents

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition in renal and hypertensive disorders

1 reference

12 December 2020

Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus

1 reference

12 December 2020

Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man

1 reference

12 December 2020

Effects of ciglitazone on endogenous plasma islet amyloid polypeptide and insulin sensitivity in obese-diabetic viable yellow mice

1 reference

12 December 2020

Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects

1 reference

12 December 2020

Calcitonin gene-related peptide: occurrence in pancreatic islets in the mouse and the rat and inhibition of insulin secretion in the mouse

1 reference

12 December 2020

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

1 reference

12 December 2020

Effects of islet amyloid polypeptide (IAPP) on insulin biosynthesis or secretion in rat islets and mouse beta TC3 cells. Biosynthesis of IAPP in mouse beta TC3 cells

1 reference

12 December 2020

Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas

1 reference

12 December 2020

Normal blood pressure in patients with insulinoma despite hyperinsulinemia and insulin resistance

1 reference

12 December 2020

Amylin inhibits insulin-stimulated glucose uptake in C2C12 muscle cell line through a cholera-toxin-sensitive mechanism

1 reference

12 December 2020

Amylin injection causes elevated plasma lactate and glucose in the rat

1 reference

12 December 2020

Inhibition of insulin release by amylin is not mediated by changes in somatostatin output

1 reference

12 December 2020

Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus

1 reference

12 December 2020

Islet amyloid polypeptide (IAPP;Amylin) influences the endocrine but not the exocrine rat pancreas

1 reference

12 December 2020

Amylin stimulates plasma renin concentration in humans.

1 reference

12 December 2020

Amylin and insulin in rat soleus muscle: dose responses for cosecreted noncompetitive antagonists

1 reference

12 December 2020

THE RELATION OE DIABETES MELLITUS TO LESIONS OF THE PANCREAS. HYALINE DEGENERATION OF THE ISLANDS OE LANGERHANS.

1 reference

12 December 2020

Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans.

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors and moderate hypertension

1 reference

12 December 2020

Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans

1 reference

12 December 2020

Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.

1 reference

12 December 2020

Insulin resistance caused by amylin in conscious rats is independent of induced hypocalcemia and fades during long-term exposure

1 reference

12 December 2020

In defence of insulin: a critique of syndrome X

1 reference

12 December 2020

8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo

1 reference

12 December 2020

Insulin-dependent diabetes mellitus and hypertension

1 reference

12 December 2020

Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes.

1 reference

12 December 2020

Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM).

1 reference

12 December 2020

Calcitonin gene-related peptide and somatostatin inhibit insulin release from individual rat B cells

1 reference

12 December 2020

8-37hCGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats

1 reference

12 December 2020

Hyalinization of the islets of Langerhans in nondiabetic individuals

1 reference

12 December 2020

The demonstration of vasodilator activity of pancreatic amylin amide in the rabbit

1 reference

12 December 2020

Anti-insulin effects of amylin and calcitonin-gene-related peptide on hepatic glycogen metabolism

1 reference

12 December 2020

Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide

1 reference

12 December 2020

Reappraisal of the role of insulin on sodium handling by the kidney: f1fect of intrarenal insulin infusion in the dog

1 reference

12 December 2020

Combined treatment of severe essential hypertension with the new angiotensin converting enzyme inhibitor ramipril

1 reference

12 December 2020

Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin

1 reference

12 December 2020

Depletion of islet amyloid polypeptide in the spontaneously diabetic (BB) Wistar rat

1 reference

12 December 2020

Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro

1 reference

12 December 2020

Inhibitory Effect of Islet Amyloid Polypeptide of Glucose-Induced Proinsulin Biosynthesis in Rat Insulinoma Cells

1 reference

12 December 2020

Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP alpha) in the fasted, anaesthetized rat.

1 reference

12 December 2020

Amylin or CGRP (8-37) fragments reverse amylin-induced inhibition of 14C-glycogen accumulation

1 reference

12 December 2020

Angiotensin-Converting Enzyme Inhibitors and Insulin Sensitivity: Metabolic Effects in Hypertension, Diabetes, and Heart Failure

1 reference

12 December 2020

Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats

1 reference

12 December 2020

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Secretion of islet amyloid polypeptide in response to glucose

1 reference

12 December 2020

Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue

1 reference

12 December 2020

In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit

1 reference

12 December 2020

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

12 December 2020

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

1 reference

12 December 2020

The Nature of the Hyaline Material in the Pancreatic Islands in Diabetes Mellitus

1 reference

12 December 2020

Amylin activates glycogen phosphorylase in the isolated soleus muscle of the rat.

1 reference

12 December 2020

Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes

1 reference

12 December 2020

Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanism

1 reference

12 December 2020

Lack of islet amyloid polypeptide regulation of insulin biosynthesis or secretion in normal rat islets

1 reference

12 December 2020

Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment

1 reference

12 December 2020

Insulin resistance, hyperinsulinemia, and obesity-associated hypertension.

1 reference

12 December 2020

Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells

1 reference

12 December 2020

The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus

1 reference

12 December 2020

Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans

1 reference

12 December 2020

On the Relation of Chronic Interstitial Pancreatitis to the Islands of Langerhans and to Diabetes Melutus

1 reference

12 December 2020

Differential short-term desensitization to vasopressin, isoproterenol, glucagon, parathyroid hormone and calcitonin in the thick ascending limb of rat kidney

1 reference

12 December 2020

Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas

1 reference

12 December 2020

Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease

1 reference

12 December 2020

Functional and structural characterization of the secretin receptors in rat gastric glands: desensitization and glycoprotein nature

1 reference

12 December 2020

Lack of Effect of Islet Amyloid Polypeptide in Causing Insulin Resistance in Conscious Dogs During Euglycemic Clamp Studies

1 reference

12 December 2020

High affinity amylin binding sites in rat brain

1 reference

12 December 2020

Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets

1 reference

12 December 2020

Chronic intrarenal hyperinsulinemia does not cause hypertension

1 reference

12 December 2020

Calcitonin gene related peptide

1 reference

12 December 2020

Antagonistic Effect of Human α-Calcitonin Gene–Related Peptide (8–37) on Regional Hemodynamic Actions of Rat Islet Amyloid Polypeptide in Conscious Long-Evans Rats

1 reference

12 December 2020

Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans

1 reference

12 December 2020

Islet amyloid polypeptide--a novel controversy in diabetes research

1 reference

12 December 2020

In vitro desensitization of isolated nephron segments to vasopressin

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition in patients with essential hypertension.

1 reference

12 December 2020

Amylin and insulin co-replacement therapy for insulin-dependent (type I) diabetes mellitus

1 reference

12 December 2020

Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

The effect of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide on glucose removal in the anaesthetized rat and on insulin secretion from rat pancreatic islets in vitro

1 reference

12 December 2020

Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats

1 reference

12 December 2020

Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey.

1 reference

12 December 2020

Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes?

1 reference

12 December 2020

Calcitonin gene-related peptide in the nervous tissue

1 reference

12 December 2020

Calcitonin gene-related peptide is a potent vasodilator

1 reference

12 December 2020

The effects of amylin on carbohydrate metabolism in skeletal muscle in vitro and in vivo

1 reference

12 December 2020

[The receptor of calcitonin gene-related peptide (CGRP) is present on the membranes of insulinoma]

1 reference

12 December 2020

Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man.

1 reference

12 December 2020

The amylin superfamily: a novel grouping of biologically active polypeptides related to the insulin A-chain

1 reference

12 December 2020

Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.

1 reference

12 December 2020

Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule.

1 reference

12 December 2020

Calcitonin gene-related peptide: potent vasodilator and major product of calcitonin gene

1 reference

12 December 2020

Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.

1 reference

12 December 2020

Insulin resistance in essential hypertension

1 reference

12 December 2020

The role of amylin in the insulin resistance of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells

1 reference

12 December 2020

Turning off the signal: desensitization of beta-adrenergic receptor function

1 reference

12 December 2020

Lilly lecture 1990. Molecular defects in diabetes mellitus

1 reference

12 December 2020

Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?

1 reference

12 December 2020

Obesity-associated hypertension. Hyperinsulinemia and renal mechanisms

1 reference

12 December 2020

Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Chronic hyperinsulinemia and blood pressure regulation.

1 reference

12 December 2020

Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle

1 reference

12 December 2020

Calcitonin gene-related peptide (CGRP) and amylin and the endocrine pancreas.

1 reference

12 December 2020

Indirect evidence for short-loop negative feedback of insulin secretion in the rat

1 reference

12 December 2020

Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Hypertension and dyslipidemia in patients with insulinoma.

1 reference

12 December 2020

Reversal of the inhibitory effects of calcitonin gene-related peptide (CGRP) and amylin on insulin secretion by the 8-37 fragment of human CGRP

1 reference

12 December 2020

10.2165/00002512-199609030-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

1023737347

0 references

1 reference